Dedication |
|
v | |
Contributors |
|
vi | |
Preface |
|
xiii | |
|
|
1 | (9) |
|
|
1 | (3) |
|
|
4 | (2) |
|
|
6 | (1) |
|
|
7 | (3) |
|
|
10 | (41) |
|
2.1 Coronary Artery Disease |
|
|
10 | (2) |
|
|
12 | (2) |
|
|
14 | (6) |
|
2.4 Pericardial Disorders |
|
|
20 | (2) |
|
|
22 | (6) |
|
2.6 Congenital Heart Disease in Adults |
|
|
28 | (3) |
|
2.7 Noncardiogenic Pulmonary Edema versus Cardiogenic Pulmonary Edema |
|
|
31 | (2) |
|
2.8 Cardiac Arrest and Resuscitation |
|
|
33 | (3) |
|
|
36 | (2) |
|
2.10 Aneurysms and Dissections |
|
|
38 | (3) |
|
2.11 Implantable Cardiac Devices |
|
|
41 | (2) |
|
|
43 | (4) |
|
2.13 Pharmacologic Therapies for Cardiac Disorders |
|
|
47 | (4) |
|
|
51 | (34) |
|
|
51 | (1) |
|
3.2 Respiratory Failure, Mechanical Ventilation, and Weaning |
|
|
52 | (4) |
|
3.3 Acute Respiratory Distress Syndrome and Acute Lung Injury |
|
|
56 | (2) |
|
3.4 Ventilator-Induced Lung Injury and Ventilator-Associated Lung Injury |
|
|
58 | (2) |
|
|
60 | (2) |
|
3.6 Pulmonary Hypertension |
|
|
62 | (3) |
|
3.7 Reactive Airway Disease (Asthma) |
|
|
65 | (2) |
|
3.8 Chronic Obstructive Pulmonary Disease (COPD) |
|
|
67 | (1) |
|
3.9 Restrictive Airway Diseases |
|
|
68 | (4) |
|
3.10 Aspiration Syndromes |
|
|
72 | (2) |
|
|
74 | (2) |
|
|
76 | (1) |
|
|
77 | (3) |
|
|
80 | (1) |
|
3.15 Sleep-Related Breathing Disorders |
|
|
81 | (2) |
|
3.16 Pharmacologic Therapies for Pulmonary Disorders |
|
|
83 | (2) |
|
Section 4 Gastrointestinal |
|
|
85 | (30) |
|
4.1 Abdominal Compartment Syndrome |
|
|
85 | (1) |
|
|
86 | (4) |
|
4.3 Gastrointestinal Perforation |
|
|
90 | (1) |
|
4.4 Acute Mesenteric Ischemia |
|
|
91 | (3) |
|
4.5 Gastrointestinal Bleeding |
|
|
94 | (2) |
|
4.6 Malabsorption in the Critically Ill Patient |
|
|
96 | (4) |
|
4.7 Ileus and Acute Colonic Pseudoobstruction (Ogilvie Syndrome) |
|
|
100 | (3) |
|
4.8 Clostridium Difficile and Toxic Megacolon |
|
|
103 | (2) |
|
4.9 Inflammatory Bowel Disease |
|
|
105 | (3) |
|
4.10 Vascular Diseases of Small Bowel |
|
|
108 | (2) |
|
|
110 | (1) |
|
4.12 Pharmacologic Therapies for Gastrointestinal Disorders |
|
|
111 | (4) |
|
|
115 | (9) |
|
5.1 Acute Kidney Injury (AKI) |
|
|
115 | (2) |
|
5.2 Infections of the Urinary Tract |
|
|
117 | (1) |
|
5.3 Acid-Base Physiology and Disorders |
|
|
118 | (2) |
|
5.4 Renal Replacement Therapy |
|
|
120 | (2) |
|
5.5 Pharmacologic Therapies for Renal Disorders |
|
|
122 | (2) |
|
|
124 | (7) |
|
6.1 Hepatic Dysfunction and Hyperbilirubinemia |
|
|
124 | (2) |
|
6.2 Hepatic Encephalopathy |
|
|
126 | (3) |
|
|
129 | (2) |
|
Section 7 Hemacology/Oncology |
|
|
131 | (16) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
135 | (3) |
|
7.6 Bone Marrow and Stem Cell Transplants |
|
|
138 | (1) |
|
|
139 | (3) |
|
|
142 | (2) |
|
7.9 Disseminated Intravascular Coagulopathy |
|
|
144 | (3) |
|
|
147 | (12) |
|
8.1 General Neuroendocrine Axis |
|
|
147 | (1) |
|
|
148 | (3) |
|
|
151 | (2) |
|
8.4 Pituitary Hormone Disorders |
|
|
153 | (2) |
|
|
155 | (2) |
|
8.6 Pharmacologic Therapies for Endocrine Disorders |
|
|
157 | (2) |
|
|
159 | (42) |
|
9.1 Altered Mental Status |
|
|
159 | (3) |
|
|
162 | (2) |
|
|
164 | (4) |
|
9.4 Central Nervous System Infections |
|
|
168 | (1) |
|
9.5 Traumatic Brain Injury and Intracranial Hypertension |
|
|
169 | (3) |
|
|
172 | (5) |
|
|
177 | (3) |
|
|
180 | (1) |
|
9.9 Subarachnoid Hemorrhage |
|
|
181 | (4) |
|
9.10 Vascular Malformations |
|
|
185 | (3) |
|
9.11 Cerebral Venous Thrombosis |
|
|
188 | (2) |
|
9.12 Demyelinating Syndromes and Prion Disease |
|
|
190 | (2) |
|
9.13 Neuromuscular Disorders |
|
|
192 | (2) |
|
|
194 | (2) |
|
9.15 Therapeutic Hypothermia |
|
|
196 | (1) |
|
9.16 Pharmacologic Therapies for Neurologic Disorders |
|
|
197 | (4) |
|
Section 10 Infectious Disease |
|
|
201 | (12) |
|
|
201 | (4) |
|
10.2 Infectious Disease and Antibiotic Therapy |
|
|
205 | (8) |
|
|
213 | (11) |
|
|
213 | (11) |
|
|
224 | (2) |
|
12.1 Dermatologic Conditions |
|
|
224 | (2) |
|
Section 13 Thermoregulation |
|
|
226 | (7) |
|
13.1 Malignant Hyperthermia |
|
|
226 | (1) |
|
13.2 Neuroleptic Malignant Syndrome |
|
|
227 | (2) |
|
|
229 | (2) |
|
|
231 | (2) |
|
|
233 | (7) |
|
14.1 Pre-eclampsia/Eclampsia and HELLP Syndrome |
|
|
233 | (3) |
|
14.2 Acute Fatty Liver of Pregnancy |
|
|
236 | (1) |
|
14.3 Amniotic Fluid Embolism |
|
|
237 | (1) |
|
14.4 Postpartum Hemorrhage |
|
|
238 | (2) |
|
Section 15 Fluids and Electrolytes |
|
|
240 | (7) |
|
15.1 Fluids and Electrolytes |
|
|
240 | (1) |
|
|
241 | (2) |
|
|
243 | (2) |
|
15.4 Calcium, Magnesium, and Phosphorous Balance |
|
|
245 | (2) |
|
|
247 | (11) |
|
16.1 Basal and Stress Energy Requirements |
|
|
247 | (3) |
|
16.2 Stress Hormone Response |
|
|
250 | (2) |
|
16.3 Nutritional Deficiency States |
|
|
252 | (2) |
|
|
254 | (2) |
|
|
256 | (2) |
|
Section 17 Pharmacokinetics and Pharmacodynamics of Drugs |
|
|
258 | (3) |
|
17.1 Basic Pharmacokinetics and Pharmacodynamics |
|
|
258 | (3) |
|
Section 18 Transfusion Therapy |
|
|
261 | (5) |
|
|
261 | (5) |
|
|
266 | (5) |
|
19.1 Transplants: Lung, Heart, Liver, and Other Organs |
|
|
266 | (5) |
|
Section 20 Trauma Management |
|
|
271 | (9) |
|
20.1 Fluid Resuscitation/Transfusion Guidelines |
|
|
271 | (2) |
|
|
273 | (2) |
|
20.3 FAST: Focused Assessment with Sonography |
|
|
275 | (3) |
|
|
278 | (2) |
|
Section 21 Pediatric Emergencies |
|
|
280 | (5) |
|
21.1 Airway and Pulmonary Emergencies |
|
|
280 | (2) |
|
21.2 Surgical Emergencies |
|
|
282 | (1) |
|
21.3 Cardiovascular Emergencies |
|
|
283 | (2) |
|
Section 22 Advanced Cardiac Life Support (ACLS) and Advanced Trauma Life Support (ATLS) |
|
|
285 | (5) |
|
22.1 ACLS and ATLS Guidelines |
|
|
285 | (5) |
|
Section 23 Point-of-Care Ultrasound in the ICU |
|
|
290 | (3) |
|
23.1 Point-of-Care Ultrasound in the ICU |
|
|
290 | (3) |
|
|
293 | (5) |
|
|
293 | (5) |
|
|
298 | (4) |
|
25.1 Nuclear, Radiologic, Chemical, and Biologic Exposures |
|
|
298 | (4) |
|
|
302 | (3) |
|
|
302 | (3) |
|
|
305 | (13) |
|
|
305 | (2) |
|
|
307 | (2) |
|
|
309 | (2) |
|
27.4 Tube Thoracostomy (Chest Tube) |
|
|
311 | (2) |
|
27.5 Thoracentesis, Paracentesis, and Pericardiocentesis |
|
|
313 | (2) |
|
27.6 Feeding Tube Placement |
|
|
315 | (3) |
|
|
318 | (3) |
|
|
318 | (3) |
|
Section 29 Epidemiology and Biostatistics |
|
|
321 | (4) |
|
29.1 Epidemiology and Biostatistics |
|
|
321 | (4) |
|
Section 30 Infection Control |
|
|
325 | (3) |
|
|
325 | (3) |
|
Section 31 ICU Administration |
|
|
328 | (4) |
|
|
328 | (4) |
|
Section 32 Ethics and Palliative Medicine |
|
|
332 | (5) |
|
32.1 Ethics and Palliative Medicine |
|
|
332 | (5) |
|
Section 33 Emergent Airway Management |
|
|
337 | (3) |
|
33.1 Emergent Airway Management |
|
|
337 | (3) |
|
Section 34 Preoperative Evaluation for Surgery |
|
|
340 | (3) |
|
34.1 Preoperative Assessment |
|
|
340 | (3) |
Questions |
|
343 | (47) |
Answers |
|
390 | (27) |
Index |
|
417 | |